Literature DB >> 4128178

An experimental basis for histamine release in contrast material reactions.

E C Lasser, A J Walters, J H Lang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4128178     DOI: 10.1148/110.1.49

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  11 in total

Review 1.  The adverse effects of angiographic radiocontrast media.

Authors:  M Westhoff-Bleck; J S Bleck; S Jost
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

Review 2.  Anaphylactoid reactions to radiocontrast material.

Authors:  P Lieberman
Journal:  Clin Rev Allergy       Date:  1991 Fall-Winter

3.  Severe adverse reactions to urography in patients taking beta-adrenergic blocking agents.

Authors:  G Hamilton
Journal:  Can Med Assoc J       Date:  1985-07-15       Impact factor: 8.262

Review 4.  Radiocontrast reactions.

Authors:  P Lieberman; R L Siegle; G Treadwell
Journal:  Clin Rev Allergy       Date:  1986-05

5.  Increased in vitro histamine release by radiographic contrast media in patients with history of incompatibility.

Authors:  J Ring; R A Simon; C M Arroyave
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

Review 6.  Anaphylaxis.

Authors:  A I Terr
Journal:  Clin Rev Allergy       Date:  1985-02

Review 7.  Contrast agents in angiocardiography.

Authors:  R Hayward; P Dawson
Journal:  Br Heart J       Date:  1984-10

8.  Africa: the real problem.

Authors: 
Journal:  CMAJ       Date:  1985-12-15       Impact factor: 8.262

9.  Human blood cells ultrastructural changes and mediator release after exposure to roentgenographic contrast media.

Authors:  M J Fritzler; J Ring; C M Arroyave; E M Tan
Journal:  Can Med Assoc J       Date:  1978-10-21       Impact factor: 8.262

10.  Hyperosmolar triggering of histamine release from human basophils.

Authors:  S R Findlay; A M Dvorak; A Kagey-Sobotka; L M Lichtenstein
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.